Prasugrel superior to ticagrelor for ACS patients who underwent PCI: JAMA MD Editorial Team19 Oct 2021 3:30 AM GMTGermany: A prespecified subgroup analysis of a randomized clinical trial revealed that among patients with acute coronary syndrome (ACS) who underwent ...
Same-day discharge after elective PCI not associated with bad outcomes: Study Dr. Shravani Dali16 Oct 2021 5:17 PM GMTSame-day discharge after elective Percutaneous Coronary Intervention (PCI) not associated with bad outcomes, suggests a study published in the JACC: ...
Marijuana use tied to higher risk of bleeding, VV accidents after PCI: JACC Study MD Editorial Team21 Sep 2021 3:30 AM GMTUSA: Marijuana usage is linked with increased risks of cerebrovascular accident and hemorrhage and a reduced risk of acute renal damage following...
Intracoronary hypothermia safe in primary PCI reveal early results of EURO-ICE trial dr. Abhimanyu Uppal15 Sep 2021 4:15 AM GMTReperfusion injury may undermine a considerable part of the recovery of the ischemic myocardium achieved by Primary PCI (percutaneous intervention). Se...
Ticagrelor monotherapy reduces bleeding risk in patients undergoing PCI with and without CKD: Study Dr. Shravani Dali8 Sep 2021 4:00 AM GMTAccording to a study published in the European Heart Journal ticagrelor monotherapy reduces significant bleeding without significantly increasing ...
No apparent benefit of Multivessel PCI among older STEMI patients: Study Dr. Shravani Dali31 Aug 2021 3:30 AM GMTMultivessel percutaneous coronary intervention (MV PCI) is not much beneficial for all older patients with ST-segment–elevation myocardial...
Revacept doesn't reduce myocardial injury risk in patients undergoing PCI: JAMA Medha22 July 2021 3:30 AM GMTGermany: The addition of revacept to standard antithrombotic therapy in patients with stable ischemic heart disease (SIHD) undergoing PCI, does not...
Clopidogrel superior to aspirin in reducing adverse events after PCI with DES: Lancet Medha9 July 2021 5:15 AM GMTClopidogrel monotherapy reduced long-term rates of all-cause mortality, non-fatal myocardial infarction, and stroke after drug-eluting stent placement ...
Periprocedural myocardial injury and MI associated with PCI- Consensus document Medha16 Jun 2021 5:00 AM GMTDelhi: The ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) has...
Guided antiplatelet therapy efficacious and safe in percutaneous coronary intervention:Lancet Dr Satabdi Saha26 April 2021 4:17 AM GMTAccording to recent research reports published in The Lancet,Guided selection of antiplatelet therapy improved both composite and individual...
Revacept may not Reduce Incidence of Myocardial Injury in patients undergoing PCI: JAMA MD Bureau5 April 2021 5:45 AM GMTRevacept, a novel platelet glycoprotein VI antagonist, in addition to currently recommended antithrombotic therapy in the setting of percutaneous...
Door-to-balloon median time of 46 minutes tied to excellent results in MI: Study Hina Zahid16 Jan 2021 8:01 AM GMTDALLAS: The longer the time between when heart attack symptoms start and a patient has an artery-clearing percutaneous coronary intervention (PCI),...
